Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Feb 1;101(3):696–702. doi: 10.1172/JCI1817

Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice.

S Vidal 1, D H Kono 1, A N Theofilopoulos 1
PMCID: PMC508615  PMID: 9449705

Abstract

Background genes determine the incidence and severity of lymphoaccumulation and histopathologic manifestations of systemic autoimmunity in mice homozygous for the apoptosis-defective Faslpr mutation. By interval mapping of 274 F2 mice intercrossed between MRL-Faslpr (severe disease) and C57BL/6-Faslpr (minimal disease), four loci were identified with significant linkage to lymphadenopathy and/ or splenomegaly on chromosomes 4, 5, 7, and 10, which were named lupus in (MRL-Faslpr x B6-Faslpr)F2 cross1-4 (Lmb1-4), respectively. Lmb1, -2, and -3 were also linked to the production of anti-dsDNA antibodies, but not glomerulonephritis, whereas Lmb4 was associated with glomerulonephritis. Lmb2, -3, and -4 were inherited from the MRL background, but interestingly, Lmb1 was derived from the C57BL16-Faslpr. Nevertheless, each locus, regardless of the strain of origin, appeared to act in an additive manner, although certain combinations were more effective. Only a single suggestive locus on chromosome 1 could be correlated with arthritis. The identification of loci with highly significant linkage to disease manifestations in Faslpr strains will make it possible to map and clone new genetic defects contributing to autoimmunity.

Full Text

The Full Text of this article is available as a PDF (253.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrus J. L., Jr, Pippin J., Joseph A., Xu C., Blumenthal D., Tamayo A., Claypool K., McCourt D., Srikiatchatochorn A., Ford R. J. Identification of a cDNA for a human high-molecular-weight B-cell growth factor. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6330–6334. doi: 10.1073/pnas.90.13.6330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boise L. H., Gottschalk A. R., Quintáns J., Thompson C. B. Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Curr Top Microbiol Immunol. 1995;200:107–121. doi: 10.1007/978-3-642-79437-7_8. [DOI] [PubMed] [Google Scholar]
  3. Brown D. M., Provoost A. P., Daly M. J., Lander E. S., Jacob H. J. Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nat Genet. 1996 Jan;12(1):44–51. doi: 10.1038/ng0196-44. [DOI] [PubMed] [Google Scholar]
  4. Burlingame R. W., Rubin R. L., Balderas R. S., Theofilopoulos A. N. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest. 1993 Apr;91(4):1687–1696. doi: 10.1172/JCI116378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chiang B. L., Bearer E., Ansari A., Dorshkind K., Gershwin M. E. The BM12 mutation and autoantibodies to dsDNA in NZB.H-2bm12 mice. J Immunol. 1990 Jul 1;145(1):94–101. [PubMed] [Google Scholar]
  6. De Bruijn M. L., Peterson P. A., Jackson M. R. Induction of heat-stable antigen expression by phagocytosis is involved in in vitro activation of unprimed CTL by macrophages. J Immunol. 1996 Apr 15;156(8):2686–2692. [PubMed] [Google Scholar]
  7. Drake C. G., Babcock S. K., Palmer E., Kotzin B. L. Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4062–4066. doi: 10.1073/pnas.91.9.4062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Drake C. G., Rozzo S. J., Hirschfeld H. F., Smarnworawong N. P., Palmer E., Kotzin B. L. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. J Immunol. 1995 Mar 1;154(5):2441–2447. [PubMed] [Google Scholar]
  9. Gilkeson G. S., Ruiz P., Pritchard A. J., Pisetsky D. S. Genetic control of inflammatory arthritis and glomerulonephritis in congenic lpr mice and their F1 hybrids. J Autoimmun. 1991 Aug;4(4):595–606. doi: 10.1016/0896-8411(91)90179-g. [DOI] [PubMed] [Google Scholar]
  10. Hang L., Theofilopoulos A. N., Dixon F. J. A spontaneous rheumatoid arthritis-like disease in MRL/l mice. J Exp Med. 1982 Jun 1;155(6):1690–1701. doi: 10.1084/jem.155.6.1690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hirose S., Sekigawa I., Ozaki S., Sato H., Shirai T. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid. Clin Exp Immunol. 1984 Dec;58(3):694–702. [PMC free article] [PubMed] [Google Scholar]
  12. Ihle J. N., Witthuhn B. A., Quelle F. W., Yamamoto K., Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol. 1995;13:369–398. doi: 10.1146/annurev.iy.13.040195.002101. [DOI] [PubMed] [Google Scholar]
  13. Izui S., Berney T., Shibata T., Fulpius T. IgG3 cryoglobulins in autoimmune MRL-lpr/lpr mice: immunopathogenesis, therapeutic approaches and relevance to similar human diseases. Ann Rheum Dis. 1993 Mar;52 (Suppl 1):S48–S54. doi: 10.1136/ard.52.suppl_1.s48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Izui S., Iwamoto M., Fossati L., Merino R., Takahashi S., Ibnou-Zekri N. The Yaa gene model of systemic lupus erythematosus. Immunol Rev. 1995 Apr;144:137–156. doi: 10.1111/j.1600-065x.1995.tb00068.x. [DOI] [PubMed] [Google Scholar]
  15. Kimura M., Matsuzawa A. Autoimmunity in mice bearing lprcg: a novel mutant gene. Int Rev Immunol. 1994;11(3):193–210. doi: 10.3109/08830189409061727. [DOI] [PubMed] [Google Scholar]
  16. Koh D. R., Ho A., Rahemtulla A., Fung-Leung W. P., Griesser H., Mak T. W. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur J Immunol. 1995 Sep;25(9):2558–2562. doi: 10.1002/eji.1830250923. [DOI] [PubMed] [Google Scholar]
  17. Kono D. H., Burlingame R. W., Owens D. G., Kuramochi A., Balderas R. S., Balomenos D., Theofilopoulos A. N. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10168–10172. doi: 10.1073/pnas.91.21.10168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kono D. H., Theofilopoulos A. N. Genetic contributions to SLE. J Autoimmun. 1996 Aug;9(4):437–452. doi: 10.1006/jaut.1996.0061. [DOI] [PubMed] [Google Scholar]
  19. Lander E., Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995 Nov;11(3):241–247. doi: 10.1038/ng1195-241. [DOI] [PubMed] [Google Scholar]
  20. Matossian-Rogers A., DeGiorgi L., Povey S. Alloimmune interactions of a lymphoproliferative disease-inducer gene Arp and linkage to Pep-7. Immunogenetics. 1983;18(6):639–648. doi: 10.1007/BF00345971. [DOI] [PubMed] [Google Scholar]
  21. Merino R., Fossati L., Lacour M., Lemoine R., Higaki M., Izui S. H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Eur J Immunol. 1992 Feb;22(2):295–299. doi: 10.1002/eji.1830220202. [DOI] [PubMed] [Google Scholar]
  22. Minota S., Yoshio T., Iwamoto M., Takeda A., Masuyama J., Mimori A., Yamada A., Kano S. Selective accumulation of anti-histone antibodies in glomeruli of lupus-prone lpr mice. Clin Immunol Immunopathol. 1996 Jul;80(1):82–87. doi: 10.1006/clin.1996.0097. [DOI] [PubMed] [Google Scholar]
  23. Morel L., Rudofsky U. H., Longmate J. A., Schiffenbauer J., Wakeland E. K. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity. 1994 Jun;1(3):219–229. doi: 10.1016/1074-7613(94)90100-7. [DOI] [PubMed] [Google Scholar]
  24. Morel L., Yu Y., Blenman K. R., Caldwell R. A., Wakeland E. K. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome. 1996 May;7(5):335–339. doi: 10.1007/s003359900098. [DOI] [PubMed] [Google Scholar]
  25. Ratkay L. G., Zhang L., Tonzetich J., Waterfield J. D. Complete Freund's adjuvant induces an earlier and more severe arthritis in MRL-lpr mice. J Immunol. 1993 Nov 1;151(9):5081–5087. [PubMed] [Google Scholar]
  26. Reap E. A., Felix N. J., Wolthusen P. A., Kotzin B. L., Cohen P. L., Eisenberg R. A. bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy. J Immunol. 1995 Dec 1;155(11):5455–5462. [PubMed] [Google Scholar]
  27. Rozzo S. J., Vyse T. J., Drake C. G., Kotzin B. L. Effect of genetic background on the contribution of New Zealand black loci to autoimmune lupus nephritis. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15164–15168. doi: 10.1073/pnas.93.26.15164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shultz L. D., Schweitzer P. A., Rajan T. V., Yi T., Ihle J. N., Matthews R. J., Thomas M. L., Beier D. R. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell. 1993 Jul 2;73(7):1445–1454. doi: 10.1016/0092-8674(93)90369-2. [DOI] [PubMed] [Google Scholar]
  29. Takahashi T., Tanaka M., Brannan C. I., Jenkins N. A., Copeland N. G., Suda T., Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 1994 Mar 25;76(6):969–976. doi: 10.1016/0092-8674(94)90375-1. [DOI] [PubMed] [Google Scholar]
  30. Theofilopoulos A. N., Dixon F. J. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269–390. doi: 10.1016/s0065-2776(08)60342-9. [DOI] [PubMed] [Google Scholar]
  31. Tsao B. P., Cantor R. M., Kalunian K. C., Chen C. J., Badsha H., Singh R., Wallace D. J., Kitridou R. C., Chen S. L., Shen N. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest. 1997 Feb 15;99(4):725–731. doi: 10.1172/JCI119217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Vidal S., Gelpí C., Rodríguez-Sánchez J. L. (SWR x SJL)F1 mice: a new model of lupus-like disease. J Exp Med. 1994 May 1;179(5):1429–1435. doi: 10.1084/jem.179.5.1429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Vyse T. J., Drake C. G., Rozzo S. J., Roper E., Izui S., Kotzin B. L. Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice. J Clin Invest. 1996 Oct 15;98(8):1762–1772. doi: 10.1172/JCI118975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vyse T. J., Kotzin B. L. Genetic basis of systemic lupus erythematosus. Curr Opin Immunol. 1996 Dec;8(6):843–851. doi: 10.1016/s0952-7915(96)80014-8. [DOI] [PubMed] [Google Scholar]
  35. Vyse T. J., Morel L., Tanner F. J., Wakeland E. K., Kotzin B. L. Backcross analysis of genes linked to autoantibody production in New Zealand White mice. J Immunol. 1996 Sep 15;157(6):2719–2727. [PubMed] [Google Scholar]
  36. Vyse T. J., Todd J. A. Genetic analysis of autoimmune disease. Cell. 1996 May 3;85(3):311–318. doi: 10.1016/s0092-8674(00)81110-1. [DOI] [PubMed] [Google Scholar]
  37. Watanabe-Fukunaga R., Brannan C. I., Copeland N. G., Jenkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992 Mar 26;356(6367):314–317. doi: 10.1038/356314a0. [DOI] [PubMed] [Google Scholar]
  38. Watson M. L., Rao J. K., Gilkeson G. S., Ruiz P., Eicher E. M., Pisetsky D. S., Matsuzawa A., Rochelle J. M., Seldin M. F. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med. 1992 Dec 1;176(6):1645–1656. doi: 10.1084/jem.176.6.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Weinberg J. B., Granger D. L., Pisetsky D. S., Seldin M. F., Misukonis M. A., Mason S. N., Pippen A. M., Ruiz P., Wood E. R., Gilkeson G. S. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med. 1994 Feb 1;179(2):651–660. doi: 10.1084/jem.179.2.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. al-Janadi M., Raziuddin S. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus. J Rheumatol. 1993 Nov;20(11):1885–1891. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES